메뉴 건너뛰기




Volumn 26, Issue 21, 2005, Pages 2251-2258

The death rate among hospitalized heart failure patients with normal and depressed left ventricular ejection fraction in the year following discharge: Evolution over a 10-year period

Author keywords

Evolution of the prognosis; Heart failure; Left ventricular systolic function

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE; SPIRONOLACTONE;

EID: 27544507282     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi383     Document Type: Article
Times cited : (33)

References (32)
  • 1
    • 0041408235 scopus 로고    scopus 로고
    • Effects of candersartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial
    • CHARM Investigators and Committees
    • McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA. CHARM Investigators and Committees. Effects of candersartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362:767-771.
    • (2003) Lancet , vol.362 , pp. 767-771
    • McMurray, J.J.1    Ostergren, J.2    Swedberg, K.3    Granger, C.B.4    Held, P.5    Michelson, E.L.6    Olofsson, B.7    Yusuf, S.8    Pfeffer, M.A.9
  • 2
    • 0033514046 scopus 로고    scopus 로고
    • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomized trial
    • The Cardiac Insufficiency Bisoprolol Study II Investigators. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial. Lancet 1999;353:9-13.
    • (1999) Lancet , vol.353 , pp. 9-13
  • 6
    • 0038486184 scopus 로고    scopus 로고
    • Prognosis for patients newly admitted to hospital with heart failure: Survival trends in 12,220 index admissions in Leicestershire 1993-2001
    • Blackledge HM, Tomlinson J, Squire IB. Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12,220 index admissions in Leicestershire 1993-2001. Heart 2003;89:615-620.
    • (2003) Heart , vol.89 , pp. 615-620
    • Blackledge, H.M.1    Tomlinson, J.2    Squire, I.B.3
  • 8
    • 1542286093 scopus 로고    scopus 로고
    • Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; data from the Swedish Hospital discharge registry 1988 to 2000
    • Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; data from the Swedish Hospital discharge registry 1988 to 2000. Eur Heart J 2004;25:300-307.
    • (2004) Eur Heart J , vol.25 , pp. 300-307
    • Schaufelberger, M.1    Swedberg, K.2    Koster, M.3    Rosen, M.4    Rosengren, A.5
  • 10
    • 0042627944 scopus 로고    scopus 로고
    • Mortality trends for 23,505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991 to 1997
    • Baker DW, Einstadter D, Thomas C, Cebul RD. Mortality trends for 23,505 Medicare patients hospitalized with heart failure in Northeast Ohio, 1991 to 1997. Am Heart J 2003;146:258-264.
    • (2003) Am Heart J , vol.146 , pp. 258-264
    • Baker, D.W.1    Einstadter, D.2    Thomas, C.3    Cebul, R.D.4
  • 11
    • 0041909380 scopus 로고    scopus 로고
    • Effects of candersartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting- enzyme inhibitors: The CHARM-Alternative trial
    • CHARM Investigators and Committees
    • Granger CB, McMurray JJ, Yusuf S, Held P, Michelson EL, Olofsson B, Ostergren J, Pfeffer MA, Swedberg K. CHARM Investigators and Committees. Effects of candersartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 2003;362:772-776.
    • (2003) Lancet , vol.362 , pp. 772-776
    • Granger, C.B.1    McMurray, J.J.2    Yusuf, S.3    Held, P.4    Michelson, E.L.5    Olofsson, B.6    Ostergren, J.7    Pfeffer, M.A.8    Swedberg, K.9
  • 12
    • 0042410539 scopus 로고    scopus 로고
    • Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM - Overall programme
    • CHARM Investigators and Committees
    • Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S. CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM - Overall programme. Lancet 2003;362:759-766.
    • (2003) Lancet , vol.362 , pp. 759-766
    • Pfeffer, M.A.1    Swedberg, K.2    Granger, C.B.3    Held, P.4    McMurray, J.J.5    Michelson, E.L.6    Olofsson, B.7    Ostergren, J.8    Yusuf, S.9    Pocock, S.10
  • 13
    • 0026704692 scopus 로고
    • Effects of the angiotensin converting enzyme inhibitors enalapril on the long term progression of left ventricular dysfunction in patients with heart failure
    • SOLVD Investigators. SOLVD Investigators
    • Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D. SOLVD Investigators. Effects of the angiotensin converting enzyme inhibitors enalapril on the long term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation 1992;86:431-438.
    • (1992) Circulation , vol.86 , pp. 431-438
    • Konstam, M.A.1    Rousseau, M.F.2    Kronenberg, M.W.3    Udelson, J.E.4    Melin, J.5    Stewart, D.6    Dolan, N.7    Edens, T.R.8    Ahn, S.9    Kinan, D.10
  • 14
    • 0010838455 scopus 로고    scopus 로고
    • Long term ACE-inhibitor therapy in patients with heart failure of left ventricular dysfunction: A systematic overview of data from individual patients
    • ACE-inhibitor myocardial infarction collaborative group
    • Flather M, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moye L, Braunwald E. Long term ACE-inhibitor therapy in patients with heart failure of left ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor myocardial infarction collaborative group. Lancet 2000;355:1575-1581.
    • (2000) Lancet , vol.355 , pp. 1575-1581
    • Flather, M.1    Yusuf, S.2    Kober, L.3    Pfeffer, M.4    Hall, A.5    Murray, G.6    Torp-Pedersen, C.7    Ball, S.8    Pogue, J.9    Moye, L.10    Braunwald, E.11
  • 15
    • 0029937949 scopus 로고    scopus 로고
    • The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
    • U.S. Carvedilol Heart Failure Study Group
    • Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:1349-1355.
    • (1996) N Engl J Med , vol.334 , pp. 1349-1355
    • Packer, M.1    Bristow, M.R.2    Cohn, J.N.3    Colucci, W.S.4    Fowler, M.B.5    Gilbert, E.M.6    Shusterman, N.H.7
  • 16
    • 0033549290 scopus 로고    scopus 로고
    • Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
    • MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure. Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-2007.
    • (1999) Lancet , vol.353 , pp. 2001-2007
  • 17
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure
    • Randomised Aldactone Evaluation Study Investigators
    • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomised Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
    • (1999) N Engl J Med , vol.341 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3    Cody, R.4    Castaigne, A.5    Perez, A.6    Palensky, J.7    Wittes, J.8
  • 19
    • 0842265892 scopus 로고    scopus 로고
    • Heart failure with preserved left ventricular systolic function
    • Hogg K, Swedberg K, McMurray JJ. Heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2004;43:317-327.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 317-327
    • Hogg, K.1    Swedberg, K.2    McMurray, J.J.3
  • 21
    • 0032741126 scopus 로고    scopus 로고
    • Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort
    • Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-1955.
    • (1999) J Am Coll Cardiol , vol.33 , pp. 1948-1955
    • Vasan, R.S.1    Larson, M.G.2    Benjamin, E.J.3    Evans, J.C.4    Reiss, C.K.5    Levy, D.6
  • 22
    • 0036342890 scopus 로고    scopus 로고
    • Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure
    • Ahmed A, Roseman JM, Duxbury AS, Allman RM, DeLong JF. Correlates and outcomes of preserved left ventricular systolic function among older adults hospitalized with heart failure. Am Heart J 2002;144:365-372.
    • (2002) Am Heart J , vol.144 , pp. 365-372
    • Ahmed, A.1    Roseman, J.M.2    Duxbury, A.S.3    Allman, R.M.4    DeLong, J.F.5
  • 24
    • 0035451308 scopus 로고    scopus 로고
    • Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function
    • Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 2001;88:530-533.
    • (2001) Am J Cardiol , vol.88 , pp. 530-533
    • Tsutsui, H.1    Tsuchihashi, M.2    Takeshita, A.3
  • 26
    • 15844399394 scopus 로고    scopus 로고
    • Heart failure in patients with preserved and deteriorated left ventricular ejection fraction: Long term prognosis
    • Varela-Roman A, Grigorian L, Barge E, Bassante P, de la Pena MG, Gonzalez-Juanatey JR. Heart failure in patients with preserved and deteriorated left ventricular ejection fraction: long term prognosis. Heart 2005;91:489-494.
    • (2005) Heart , vol.91 , pp. 489-494
    • Varela-Roman, A.1    Grigorian, L.2    Barge, E.3    Bassante, P.4    De La Pena, M.G.5    Gonzalez-Juanatey, J.R.6
  • 27
    • 0037369269 scopus 로고    scopus 로고
    • Beta blockers in patients with congestive heart failure: Guided use in clinical practice Investigators. Treatment of chronic heart failure with beta-adrenergic blockade beyond controlled clinical trials: The BRING UP experience
    • Maggioni AP, Sinagra G, Opasisch C, Geraci E, Gorini M, Gronda E, Lucci D, Tognoni G, Balli E, Tavazzi L. Beta blockers in patients with congestive heart failure: guided use in clinical practice Investigators. Treatment of chronic heart failure with beta-adrenergic blockade beyond controlled clinical trials: the BRING UP experience. Heart 2003;89:299-305.
    • (2003) Heart , vol.89 , pp. 299-305
    • Maggioni, A.P.1    Sinagra, G.2    Opasisch, C.3    Geraci, E.4    Gorini, M.5    Gronda, E.6    Lucci, D.7    Tognoni, G.8    Balli, E.9    Tavazzi, L.10
  • 31
    • 0041408234 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved trial
    • CHARM Investigators and Committees
    • Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J. CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial. Lancet 2003;362:777-781.
    • (2003) Lancet , vol.362 , pp. 777-781
    • Yusuf, S.1    Pfeffer, M.A.2    Swedberg, K.3    Granger, C.B.4    Held, P.5    McMurray, J.J.6    Michelson, E.L.7    Olofsson, B.8    Ostergren, J.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.